This stunning scientific achievement is the result of a full decade of tireless research and international collaboration, putting an invaluable tool in the hands of researchers that could change the course of humanity’s war against malignant diseases and their treatment in the future.

• Introduction to the scientific and historical breakthrough
• A comprehensive reference tool designed to support medical discoveries
• Biological models that accurately reflect real tumor characteristics
• Expanding access and exchanging scientific knowledge with researchers
• Strategic importance in personalized medicine and future treatments
• Frequently asked questions about the encyclopedia and the new database

Introduction to the scientific and historical breakthrough

A large alliance of top international scientists and researchers revealed the largest dataset and advanced library of biological models derived directly from cancer patients to date on Wednesday, in a deep and historic scientific study whose complex and precise details were published in the prestigious and widely circulated scientific journal Nature. This massive and detailed medical record is the culmination of a full decade of collaboration and hard work within a massive medical initiative known as the Human Cancer Models Initiative, a global project actively and professionally led by the U.S. National Cancer Institute in close and fruitful cooperation with leading medical institutions such as Cancer Research UK, the Wellcome Sanger Institute, and the Hubrecht Organoid Technology authority. This ambitious and exceptional initiative aims to provide a huge interactive platform and supply researchers and doctors around the world with unprecedented, powerful experimental tools that efficiently help them delve into the complex and thorny biology of tumors, ultimately accelerating the pace of drug discovery and the development of personalized, targeted treatments for each individual case with extreme precision, thereby increasing cure rates and reducing side effects.

A comprehensive reference tool designed to support medical discoveries

This huge and unique collection includes up to 665 advanced and validated laboratory models, developed and scientifically maintained based on real, live samples carefully taken from 2,780 donors suffering from various types of cancer, covering 25 different types of known and common malignancies. Out of this total and scientifically impressive number, 522 laboratory models contain highly detailed and precise clinical medical data on patient histories, while 153 models exclusively and intensively highlight extremely rare types of cancers that contemporary medicine usually lacks sufficient and adequate studies on to understand their behavior and treatment methods. Most importantly, 71 models from this highly valuable collection were derived from patients of non-European ethnic origins, significantly enhancing the comprehensiveness and diversity of the data and helping physicians understand the impact of different genetic factors with greater accuracy. Every biological model in this library is linked and synchronized with very deep and complex data regarding genomic characteristics, epigenetic genes, and transcriptomic sequences, creating integrated molecular profiles that directly help scientists link the nature and characteristics of the individual tumor to the outcomes and results of laboratory experiments. Commenting on this prominent scientific and milestone event, Anthony Letai, director of the National Cancer Institute, said: “By tightly and precisely combining models derived directly from patients with deep molecular and clinical data, this historic initiative has laid solid foundations for improving our deep understanding of how cancer works and grows, and for effectively improving the desired outcomes for treating these patients in the future.”>

Biological models that accurately reflect real tumor characteristics

Perhaps one of the most important and prominent central discoveries emerging from this long and arduous research is the conclusive and precise proof that biological models grown and developed inside laboratory tubes are indeed fully capable of retaining the essential and precise biological characteristics of the original tumors extracted from patients’ bodies. Deep medical analysis covering 421 matched samples between the original tumor in the body and the cultured biological model revealed an astonishing and genuine concordance rate of 97.8 percent regarding core and pivotal genetic alterations, as well as a matching and similarity rate of up to 95 percent at the level of epigenetic genetic traits, in addition to an astonishing 92 percent similarity in expression patterns and ribonucleic acid composition. What further added to the scientists’ admiration and pride is that these encouraging percentages remained completely stable and constant even after cultivating and growing these models for relatively long periods under controlled and isolated laboratory conditions. Prominent researcher Louis Staudt from the institute’s cancer research center said: “The conditions provided for tissue culture never noticeably distorted or altered the precise genetic makeup or vital phenotypic patterns in a way that hinders their study. Our steadfast hope and ambition are that this very strong and close similarity between the actual patient tumor and the biological model will allow scientists and doctors to use it very effectively to diagnose biological vulnerabilities and exploit them therapeutically and medically to strike the disease hard.” The American Tissue Culture Collection, the exclusive and authorized distributor to provide this rare collection, described this historic study as “representing par excellence the independent, reliable, and published validation our scientific field needs to support the development of advanced models with greater confidence.”

Expanding access and exchanging scientific knowledge with researchers

Researchers and project organizers clearly emphasized that all of these complex genetic models have already been placed at the disposal and accessibility of the entire scientific and medical community via the approved and official distribution institution, accompanied by all their specific, detailed genomic, clinical, and biological databases for analysis and study. The importance and benefits of this prominent event are not limited to the main research paper alone; its publication in Nature is accompanied by companion studies prepared by prominent, independent researchers from the Wellcome Sanger Institute, the Broad Institute of MIT and Harvard, and Cold Spring Harbor Laboratory. For example, in a direct practical and realistic application, the use of this new knowledge and research treasure in research related to brain cancer and glioblastoma tumors yielded actual and important discoveries regarding specific genetic traits closely associated with this fierce disease’s resistance to the well-known chemotherapy drug temozolomide, strongly and steadily demonstrating the direct and important practical value of this database in confronting one of the hardest challenges in oncology treatment: the phenomenon of ongoing medical treatment resistance. Peter Laird of the Van Andel Institute, a prominent co-author of the great study, said: “These medical models represent a very vivid and excellent representation of original tumors and their complex pathways. We feel extremely enthusiastic about sharing and publishing this immense wealth of knowledge with all researchers and laboratories, and we have every hope and confidence that our collective contribution will accelerate the pace of innovation and groundbreaking, successful discoveries to cure this debilitating disease.”

Strategic importance in personalized medicine and future treatments

In the very near future, such stunning databases may provide the golden opportunity to design customized, individualized treatment protocols for each patient based on their precise genetic fingerprint and unique tumor makeup. This revolutionary medical approach will inevitably lead to avoiding general and ineffective chemotherapy treatments, significantly reducing toxic side effects, and increasing the chances of cure and survival from intractable and rare diseases with unprecedented effectiveness.

Frequently asked questions about the encyclopedia and the new database

Question: What is the critical importance of the newly published dataset on cancer research models?

Answer: It represents the largest available library of biological models derived from real patients, providing unprecedented and powerful tools to understand tumor interaction and develop efficient, personalized, and targeted treatments.

Question: How many donor patients and cancer types does this extensive medical study include and cover?

Answer: It includes and covers data and live models taken from 2,780 affected donors across 25 different types, including data and rare, complex types that are medically difficult to study.

Question: What is the actual genetic match level between the actual tumor in the patient’s body and the cultured model in the medical laboratory?

Answer: All in-depth laboratory analyses showed a tremendous match reaching an actual rate of 97.8 percent at the level of basic genetic alterations and characteristics, ensuring the accuracy of experiments and research.

Question: How will these cultured laboratory models help improve and develop future cancer treatment methods for patients?

Answer: They will help researchers in major institutions safely test drugs in the laboratory on samples matching patient tumors to determine treatment efficacy and discover ways to overcome medical tumor resistance.